Allworth Financial’s AnaptysBio ANAB Stock Holding History

Allworth Financial’s Portfolio ANAB Stock Details ANAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$10.1K	Sell	150 -4	-3%	-$242	﹤0.01%	3705
2026 Q1	$8.54K	Buy	154 +11	+8%	+$592	﹤0.01%	3617
2025 Q4	$6.93K	Sell	143 -528	-79%	-$20.6K	﹤0.01%	3513
2025 Q3	$20.5K	Sell	671 -6	-0.9%	-$138	﹤0.01%	2692
2025 Q2	$15K	Sell	677 -10	-1%	-$209	﹤0.01%	2688
2025 Q1	$14.2K	Buy	+687	New	+$11.5K	﹤0.01%	2272
2023 Q4	–	Sell	-78	Closed	-$1.4K	–	3465
2023 Q3	$1.4K	Hold	78	–	–	﹤0.01%	2709
2023 Q2	$1.59K	Hold	78	–	–	﹤0.01%	2577
2023 Q1	$1.7K	Hold	78	–	–	﹤0.01%	2473
2022 Q4	$2.42K	Hold	78	–	–	﹤0.01%	2175
2022 Q3	$2K	Hold	78	–	–	﹤0.01%	2096
2022 Q2	$2K	Hold	78	–	–	﹤0.01%	1977
2022 Q1	$2K	Hold	78	–	–	﹤0.01%	1770
2021 Q4	$3K	Hold	78	–	–	﹤0.01%	1626
2021 Q3	$2K	Hold	78	–	–	﹤0.01%	1654
2021 Q2	$2K	Hold	78	–	–	﹤0.01%	1352
2021 Q1	$2K	Buy	+78	New	+$1.97K	﹤0.01%	1283

Other funds holding ANAB

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AAA

Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return

Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Allworth Financial's ANAB Position: Q2 2026 in Review

Allworth Financial reduced its AnaptysBio (ANAB) stake by 2.6% in Q2 2026, selling an estimated $242 and leaving 150 shares worth $10.1K. The position accounts for ﹤0.01% of the portfolio, ranked #3705.

Allworth Financial first reported a position in ANAB in Q1 2021 and has held it in 17 quarters since. The position peaked at $20.5K in Q3 2025. 213 funds tracked by Wall St. Rank hold ANAB as of Q2 2026.

Allworth Financial held 150 shares of AnaptysBio worth $10.1K as of Q2 2026.
Allworth Financial sold 4 AnaptysBio shares in Q2 2026, an estimated $242.
AnaptysBio made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #3705 holding.
Allworth Financial first reported a position in AnaptysBio in Q1 2021 and has held it in 17 quarters since.
Allworth Financial's AnaptysBio position peaked at $20.5K in Q3 2025.
213 funds tracked by Wall St. Rank held AnaptysBio as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.